Search Results - "RATHGEB, F"

  • Showing 1 - 12 results of 12
Refine Results
  1. 1

    Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma by Ukena, D, Harnest, U, Sakalauskas, R, Magyar, P, Vetter, N, Steffen, H, Leichtl, S, Rathgeb, F, Keller, A, Steinijans, VW

    Published in The European respiratory journal (01-12-1997)
    “…The anti-asthmatic effects of theophylline may supplement those of inhaled steroids in asthma. The aim of the present trial was to study how the addition of…”
    Get full text
    Journal Article
  2. 2

    Dyeless optical detection of ammonia in the gas phase using pH-responsive polymers with reflectometric interference spectroscopy by Rathgeb, F., Gauglitz, G.

    Published in Analytica chimica acta (26-10-1998)
    “…Polymers sensitive to pH were investigated to determine their potential as sensing elements for ammonia. Polymethacrylic acid and a modified polysiloxane…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Asthma management: the challenge of equivalence by Steinijans, V W, Neuhäuser, M, Hummel, T, Leichtl, S, Rathgeb, F, Keller, A

    “…Increasing prevalence and severity of asthma worldwide encourage the development of new antiasthmatic drugs, alternative treatment regimens and improved…”
    Get more information
    Journal Article
  5. 5

    Phase I and pharmacokinetic study of the P-glycoprotein modulator dexniguldipine-HCL by Nuessler, V, Scheulen, M E, Oberneder, R, Kriegmair, M, Goebel, K J, Rathgeb, F, Wurst, W, Zech, K, Wilmanns, W

    Published in European journal of medical research (21-02-1997)
    “…Dexniguldipine (DNIG) is the R-enantiomer of the dihydropyridine derivate niguldipine. DNIG showed a binding affinity to the P-glycoprotein (P-gp) and…”
    Get more information
    Journal Article
  6. 6

    Tolerance, safety, and kinetics of the new antineoplastic compound dexniguldipine-HCl after oral administration: a phase I dose-escalation trial by Ukena, D, Boewer, C, Oldenkott, B, Rathgeb, F, Wurst, W, Zech, K, Sybrecht, G W

    “…Dexniguldipine-HCl is a new dihydropyridine compound that exerts selective antiproliferative activity in a variety of tumor models and, in addition, has a high…”
    Get full text
    Journal Article
  7. 7
  8. 8

    Bioavailability and pharmacokinetic characteristics of dexniguldipine-HCl, a new anticancer drug by Goedhals, L, Bezwoda, W R, Abratt, R P, Rathgeb, F, Goebel, K J, Wurst, W

    “…Dexniguldipine-HCl is a new dihydropyridine derivative with antineoplastic activity and potency for overcoming multidrug resistance. In this pharmacokinetic…”
    Get more information
    Journal Article
  9. 9

    Interaction between volatile organic compounds and cyclopeptides detected with reflectometric interference spectroscopy by Leipert, Dietmar, Rathgeb, Frank, Herold, Martin, Mack, Jürgen, Gauglitz, Günter, Jung, Günther

    Published in Analytica chimica acta (21-06-1999)
    “…Cyclohexapeptides, which were bound covalently to an interference layer, were tested as new chemoreceptors for interaction with volatile organic compounds…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Comparison of addition of theophylline to inhaled steroid with doubling of the dose of inhaled steroid in asthma by Ukena, D, Harnest, U, Sakalauskas, R, Magyar, P, Vetter, N, Steffen, H, Leichtl, S, Rathgeb, F, Keller, A, Steinijans, V W

    Published in Pneumologie (Stuttgart, Germany) (01-07-1998)
    “…The anti-asthmatic effect of theophylline may supplement those of inhaled steroids in asthma. The aim of the present trial was to study how the addition of…”
    Get more information
    Journal Article
  12. 12